Analysis of cytokine production by peanut‐reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2222|45|7|1201-1213

ISSN： 0954-7894

Source： CLINICAL & EXPERIMENTAL ALLERGY, Vol.45, Iss.7, 2015-07, pp. : 1201-1213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Safety of Peanut Oral Immunotherapy in Peanut-Allergic Subjects in a Single-Center Trial

By  

International Archives of Allergy and Immunology, Vol. 159, Iss. 2, 2012-06 ,pp. : 179-182

Karger

Access to resources Recommend Favorite

Modulation of Peanut‐specific humoral and cellular responses pre‐ and post‐oral immunotherapy

By  

CLINICAL & EXPERIMENTAL ALLERGY, Vol. 45, Iss. 7, 2015-07 ,pp. : 1146-1149

John Wiley & Sons Inc

Access to resources Recommend Favorite

The longitudinal impact of probiotic and peanut oral immunotherapy on health‐related quality of life

By  

ALLERGY, Vol. 73, Iss. 3, 2018-03 ,pp. : 560-568

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Allergy to Hazelnut and Peanut: Identification of T Cell Cross-Reactive Allergens

By  

International Archives of Allergy and Immunology, Vol. 155, Iss. 4, 2011-02 ,pp. : 345-354

Karger

Access to resources Recommend Favorite

Half of the children who received oral immunotherapy for a cows' milk allergy consumed milk freely after 2.5 years

By  

ACTA PAEDIATRICA, Vol. 104, Iss. 11, 2015-11 ,pp. : 1164-1168

John Wiley & Sons Inc

Access to resources Recommend Favorite